Ambrisentan
Ambrisentan is an endothelin receptor antagonist used in the therapy of pulmonary arterial hypertension (PAH). Ambrisentan has been associated with a low rate of serum enzyme elevations during therapy but has yet to be implicated in cases of clinically apparent acute liver injury.
| Catalog Number | T1655 |
| Alternative Name(s) | BSF-208075 , BSF 208075 , LU 208075 |
| Research Area | GPCR/G Protein |
| Molecular Formula | C22H22N2O4 |
| CAS# | 177036-94-1 |
| Purity | 99.85% |
| SMILES | COC([C@H](Oc1nc(C)cc(C)n1)C(O)=O)(c1ccccc1)c1ccccc1 |
| Size | 25 mg |
| Supplier Page | https://www.targetmol.com/compound/Ambrisentan |
| Additional Information | https://www.targetmol.com/datasheet/T1655 |